| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/06/2007 | CN1973881A Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
| 06/06/2007 | CN1973880A Externally applied medicine for treating gouty arthritis and its prepn |
| 06/06/2007 | CN1973866A Quality control method for cold treating and cough relieving syrup |
| 06/06/2007 | CN1973853A Hemostatic and analgetic medicine composition and its prepn process |
| 06/06/2007 | CN1973836A Hydrophilic plaster for treating dysmenorrhea |
| 06/06/2007 | CN1973831A Magnetic slow releasing diclofenac sodium prepn in supermolecular intercalation structure and its prepn |
| 06/06/2007 | CN1973827A Prepn process of superfine inhaled glucocorticoid medicine powder |
| 06/06/2007 | CN1319973C Piperidine derivatives |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/06/2007 | CN1319959C Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/06/2007 | CN1319571C Chinese patent medicine for enterogastric heat retention waist and knee aching pain and joint tingling and its preparation |
| 06/06/2007 | CN1319568C Rheumatism treating plaster and its prepn |
| 06/06/2007 | CN1319566C Ointment for treating rheumatic disease |
| 06/06/2007 | CN1319560C Chinese medicine compound rheumatism preparation for improving bioavailability and medicine effect and preparing method |
| 06/06/2007 | CN1319540C Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 06/06/2007 | CN1319538C Preparation method of Astragaloside material medicine, the material medicine and preparation |
| 06/06/2007 | CN1319534C Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 06/06/2007 | CN1319524C Turmeria oil extract dripping pill, its preparation method and application |
| 06/06/2007 | CN1319518C Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227038 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 06/05/2007 | US7227031 Aspirin-triggered lipoxins as modulators of diseases associated with polymorphoneutrophil inflammation; antiinflammatory agents |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7226995 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 06/05/2007 | US7226945 Estrogen receptor-β ligands |
| 06/05/2007 | US7226943 Antilipemic agents |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226936 Pyridinic sulfonamide derivatives method of production and use thereof |
| 06/05/2007 | US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 06/05/2007 | US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use |
| 06/05/2007 | US7226616 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2368400C Macrolides with anti-inflammatory activity |
| 06/05/2007 | CA2293836C Polymorphic form of a tachykinin receptor antagonist |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 06/05/2007 | CA2125644C Pharmaceutical compositions containing the salts of s(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids |
| 05/31/2007 | WO2007062410A1 Imidazole derivatives as nitric oxide synthase dimerisation inhibitor |
| 05/31/2007 | WO2007062325A1 Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 05/31/2007 | WO2007062175A2 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 05/31/2007 | WO2007061978A1 Spirocyclic compounds as hdac inhibitors |
| 05/31/2007 | WO2007061912A2 High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 05/31/2007 | WO2007061880A1 Spirocyclic compounds as hdac inhibitors |
| 05/31/2007 | WO2007061828A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061739A2 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | WO2007061679A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 05/31/2007 | WO2007061237A1 Composition for anti-inflammation |
| 05/31/2007 | WO2007060992A1 Agent for preventing or improving metabolic syndrome or insulin-resistance syndrome |
| 05/31/2007 | WO2007060979A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 05/31/2007 | WO2007060769A1 Lipopolysaccharide or lipid a binder and novel peptide |
| 05/31/2007 | WO2007060715A1 Method of screening interleukin-6 (il-6) signal transduction inhibitor |
| 05/31/2007 | WO2007060198A1 Pyrazoloisoquinoline derivatives |
| 05/31/2007 | WO2007060112A1 Salicylic acid derivatives |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007059949A1 Two novel salts of the n, n' -bis [9- (3,4-dihydroxy-5- (2-ethyl-2h-tetrazol-5-yl) tetrahydrofuran-2-yl) -2- (2- (1-methyl-1h-imidazol-4-yl) ethylamino) -9h-purin-6-yl] cyclohexyl-1,4-diamine adenosine a2a agonist as anti-inflammatory agents |
| 05/31/2007 | WO2007059905A2 Thienopyrimidines treating inflammatory diseases |
| 05/31/2007 | WO2007059574A1 A molecule and chimeric molecules thereof |
| 05/31/2007 | WO2007041077A3 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2007030089A8 Tricyclic delta- opioid modulators |
| 05/31/2007 | WO2007016525A3 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 05/31/2007 | WO2007006041A3 Imaging and therapeutic method using monocytes |
| 05/31/2007 | WO2006127900A3 Tl1a in the treatment of disease |
| 05/31/2007 | WO2006067312A3 Painkilling association comprising a dihydroimidazopyrazine derivative |
| 05/31/2007 | WO2006015318A3 Antibody conjugated to a drug moiety via a poptidic linker |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123543 Novel compounds |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123510 Guanidine derivatives |
| 05/31/2007 | US20070123503 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123455 Immunomodulatory agents for treatment of inflammatory diseases |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122475 Taste masking composition |
| 05/31/2007 | DE102005057421A1 New heteroaromatic sulfonamide prodrugs, useful for delivering e.g. antimalarials and steroids for e.g. fertility control or hormone replacement therapy |
| 05/31/2007 | CA2630907A1 Pyrazoloisoquinoline derivatives |
| 05/31/2007 | CA2630805A1 Salicylic acid derivatives |
| 05/31/2007 | CA2630752A1 Method of modulating stress-activated protein kinase system |
| 05/31/2007 | CA2630145A1 High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 05/31/2007 | CA2630072A1 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | CA2629560A1 Pharmaceutical compositions comprising buprenorphine |
| 05/31/2007 | CA2629160A1 Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 05/31/2007 | CA2629147A1 Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin |
| 05/31/2007 | CA2628146A1 Salts of inducible nitric oxide synthase dimerization inhibitors |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1790348A2 Use of uridine for the treatment of inflammations and/or hemostasis |
| 05/30/2007 | EP1790341A1 Medicine having analgesic effects |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1789428A1 Monosaccharide derivatives |
| 05/30/2007 | EP1789422A1 Anti-inflammatory compounds |
| 05/30/2007 | EP1789417A1 AMIDE DERIVATIVES OF 7-AMINO-3-PHENYL-DIHYDROPYRIMIDO [4,5-d]PYRIMIDINONES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS |
| 05/30/2007 | EP1789413A1 Vanilloid receptor ligands and their use in treatments |